Cellomics Inc.
This article was originally published in Start Up
Executive Summary
Cellomics Inc. aims to use its screening technology to determine the activity of a drug at the cellular level.
You may also be interested in...
Start-Ups in High Throughput Screening
Companies in the new generation of screening technologies are stressing content as much as they're stressing speed, and one-stop shopping as much as focused expertise.
Women's Health: Too early or Too Late?
As an industry, women's health is in its infancy. It has yet to develop beyond a collection of niche specialties in reproductive medicine and breast cancer.
EPIcyte Pharmaceutical Inc.
EPIcyte has licensed patents from the Scripps Research Institute covering new methods of human antibody production in plants that can lower costs up to 100 fold. The company is also developing proprietary products based on its technology, initially, an anti-herpes prophylactic and a contraceptive based on an anti-sperm antibody.